Drug Shortage Report for URSO DS
| Report ID | 95285 |
| Drug Identification Number | 02245894 |
| Brand name | URSO DS |
| Common or Proper name | ursodiol |
| Company Name | APTALIS PHARMA CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | URSODIOL |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A05AA |
| ATC description | BILE THERAPY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-10-03 |
| Actual start date | 2019-10-03 |
| Estimated end date | 2019-10-18 |
| Actual end date | 2019-10-22 |
| Shortage status | Resolved |
| Updated date | 2019-10-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: [email protected] Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-10-23 | English | Compare |
| v5 | 2019-10-22 | French | Compare |
| v4 | 2019-10-22 | English | Compare |
| v3 | 2019-10-04 | English | Compare |
| v2 | 2019-10-03 | French | Compare |
| v1 | 2019-10-03 | English | Compare |
Showing 1 to 6 of 6